- $576.86m
- $631.46m
- $41.51m
- 81
- 28
- 73
- 64
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 23.8 | 23.6 | 31.2 | 37.5 | 41.5 |
Cost of Revenue | |||||
Gross Profit | 8.31 | 8.64 | 5.34 | 11.7 | 15.7 |
Selling / General / Administrative Expenses | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 18 | 18.4 | 28.9 | 29.5 | 29.8 |
Operating Profit | 5.76 | 5.13 | 2.27 | 8 | 11.7 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 11.8 | 14.9 | 50.4 | 5.58 | 6.4 |
Provision for Income Taxes | |||||
Net Income After Taxes | 8.82 | 11.7 | 40.1 | 4.05 | 4.88 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 16.2 | 12.7 | 28.2 | 4.57 | 5.3 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 16.2 | 12.7 | 28.2 | 4.57 | 5.3 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.445 | 0.287 | -0.295 | 0.208 | 0.278 |